INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 47 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $26,306 | +31.6% | 124,968 | 0.0% | 0.00% | – |
Q1 2023 | $19,995 | -71.2% | 124,968 | 0.0% | 0.00% | – |
Q4 2022 | $69,357 | -53.5% | 124,968 | 0.0% | 0.00% | – |
Q3 2022 | $149,000 | +204.1% | 124,968 | +62.3% | 0.00% | – |
Q2 2022 | $49,000 | -61.4% | 76,991 | -31.1% | 0.00% | – |
Q1 2022 | $127,000 | -49.6% | 111,783 | 0.0% | 0.00% | – |
Q4 2021 | $252,000 | -34.2% | 111,783 | -0.3% | 0.00% | – |
Q3 2021 | $383,000 | -93.3% | 112,100 | -74.8% | 0.00% | -100.0% |
Q2 2014 | $5,676,000 | +7.2% | 445,500 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $5,297,000 | -11.9% | 445,500 | +2.4% | 0.00% | 0.0% |
Q4 2013 | $6,010,000 | -9.7% | 435,200 | +14.0% | 0.00% | -25.0% |
Q3 2013 | $6,659,000 | +41.3% | 381,600 | +31.5% | 0.00% | +33.3% |
Q2 2013 | $4,714,000 | – | 290,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
Bleichroeder LP | 250,000 | $530,000 | 0.10% |
PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |